Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia

Table 4

The comparison of the Treg cells level between patients with SR and with non-SR.

		Before the treatment (%)	During the follow-up phase (%)
The rapamycin group
SR	17	5.17±1.50	6.94±1.40^※
Non-SR	8	5.5±1.65	6.01±1.22
The cyclosporine A group
SR	11	5.84±1.82	6.07±1.14
Non-SR	17	5.49±1.39	5.11±1.01

^※𝑃<0.005, comparing the Treg cells level before the treatment to that during the follow-up phase in the rapamycin group.